MARKET

ARGX

ARGX

Argenx
NASDAQ

Real-time Quotes | Nasdaq Last Sale

157.01
-4.09
-2.54%
Opening 10:44 02/24 EST
OPEN
157.10
PREV CLOSE
161.10
HIGH
158.51
LOW
156.72
VOLUME
60.66K
TURNOVER
--
52 WEEK HIGH
169.50
52 WEEK LOW
106.49
MARKET CAP
6.71B
P/E (TTM)
-53.3069
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ARGX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ARGX stock price target is 180.13 with a high estimate of 253.99 and a low estimate of 145.42.

EPS

ARGX News

More
  • Benzinga's Top Upgrades, Downgrades For February 10, 2020
  • Benzinga · 02/10 15:20
  • B of A Securities Initiates Coverage On argenx with Buy Rating
  • Benzinga · 02/10 12:06
  • Our Take On argenx SE's (EBR:ARGX) CEO Salary
  • Simply Wall St. · 02/09 08:01
  • Morgan Stanley Maintains Overweight on argenx, Raises Price Target to $180
  • Benzinga · 01/17 13:19

Industry

Biotechnology & Medical Research
-2.41%
Pharmaceuticals & Medical Research
-2.24%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About ARGX

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.
More

Webull offers kinds of argenx SE - ADR stock information, including NASDAQ:ARGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARGX stock news, and many more online research tools to help you make informed decisions.